If you are a current Jazz employee please apply via the Internal Career site
Jazz Pharmaceuticals is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.
Job DescriptionUS Field-Based role focusing on the Southeast
Essential Functions
Serve as the first-line Jazz medical point of contact for clinical, health outcomes, and real-world evidence, and provide support across therapeutic areas to key national formulary decision-makers in a manner consistent with Jazz’ principles for scientific engagement.
Develop Scientific Account Plans with strategic tactics for key accounts that demonstrate a deep understanding of payer’s population-management strategies, scientific priorities, evidence needs, decision-making processes, and clinical perspectives on Jazz products.
Build relationships and establish scientific and professional credibility within national managed care organizations, health care systems, government payers, and with other stakeholders involved in formulary management, medication positioning, value discussions and health care policy.
Engage in credible and transparent scientific information exchange that resonates with payers when responding to unsolicited requests for clinical, health outcomes and pharmacoeconomic information and proactively communicates HCEI in alignment with the 21st Century Cure’s Act.
Provide customer insights to internal teams on key evidence gaps relevant to health care decision makers to guide GHEOR, RWE and Clinical team’s strategic development of impactful value evidence generation and clinical development plans for marketed and pipeline products.
Facilitate educational and collaborative research opportunities, and partner with GHEOR and RWE to conduct and publish HEOR and HCEI in alignment with Jazz’ standard operating procedures (SOPs).
Collaborate with cross-functional partners on the development of educational tools and resources (disease state education, payer-focused slide decks, Medicaid testimony, economic models, etc.) communicated to customers to improve relevant therapeutic area understanding and access to Jazz’ marketed and pipeline products.
Implement and execute scientific training for the PVO team and cross-functional partners (ARM, Field Payer/Market Access teams and HEOR).
Collaborate with the Medical Affairs trainer and Medical Science Liaison (MSL) management to provide managed markets training and mentorship for MSLs.
Collaborate and build strong relationships with cross-functional partners and internal stakeholders and ensure continuous and consistent communication on activities/projects.
Represent PVO as the technical/medical payer expert on cross-functional internal teams.
Ensure compliance with all applicable laws, regulations and regulatory guidelines governing commercial and scientific interactions with healthcare professionals, payers, advocacy and other business partners.
Required Knowledge, Skills, and Abilities
Minimum of 5 years of post-doctoral relevant scientific work experience in a pharmaceutical industry or managed markets setting (Managed Care/PBM, VA/DoD, CMS, State Medicaid, etc.), payer strategy, clinical practice, outcomes and/or related disciplines, with 2 of these years in a field-based payer/outcomes role
Demonstrated proficiency in managing and maintaining knowledge in multiple therapeutic areas (neurology, hematology and oncology is strongly preferred) and strategic initiatives including health outcomes, quality initiatives, consensus standards, evidence-based guidelines and health care policy
In-depth knowledge of the biopharmaceutical industry and US managed markets, including various access and reimbursement models (Managed Care, Medicare Part B, Part D and Medicaid, etc.)
Demonstrated expertise in health outcomes, health care policy, health technology assessment, and pharmacoeconomic principles including AMCP Dossiers, PIE Act, 21st Century Cures Act, Institute for Clinical and Economic Review (ICER) and pharmacoeconomic models as well as their application to evaluate and deliver the value of medicines
Excellent analytical, written, and verbal communication and experience presenting critical medical, health economic data and business information to internal stakeholders and external national payer customers
Strong strategic-thinking skills; demonstrated ability to network and identify opportunities for medical engagement, set scientific engagement goals, and create and influence value propositions for innovative medicines and services
Strong personal integrity, interpersonal skills, teamwork abilities and customer focus.
Demonstrated ability to organize, adapt, prioritize, and work effectively in a matrixed organization and in an evolving/changing health care environment.
Ability to travel approximately 50-60% time
Required/Preferred Education and Licenses
Advanced degree in the health sciences (MD, PharmD, PhD) is required. An additional master’s degree in business or health economics is preferred (e.g. MBA, MS)
Jazz Pharmaceuticals is an equal opportunity/affirmative action employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any characteristic protected by law.
FOR US BASED CANDIDATES ONLY
Jazz Pharmaceuticals, Inc. is committed to fair and equitable compensation practices and we strive to provide employees with total compensation packages that are market competitive. For this role, the full and complete base pay range is:
$172,000.00 - $258,000.00Individual compensation paid within this range will depend on many factors, including qualifications, skills, relevant experience, job knowledge, and other pertinent factors. The goal is to ensure fair and competitive compensation aligned with the candidate's expertise and contributions, within the established pay framework and our Total Compensation philosophy. Internal equity considerations will also influence individual base pay decisions. This range will be reviewed on a regular basis.
At Jazz, your base pay is only one part of your total compensation package. The successful candidate may also be eligible for a discretionary annual cash bonus or incentive compensation (depending on the role), in accordance with the terms of the Company's Global Cash Bonus Plan or Incentive Compensation Plan, as well as discretionary equity grants in accordance with Jazz’s Long Term Equity Incentive Plan.
The successful candidate will also be eligible to participate in various benefits offerings, including, but not limited to, medical, dental and vision insurance, 401k retirement savings plan, and flexible paid vacation. For more information on our Benefits offerings please click here: https://careers.jazzpharma.com/benefits.html
Skills Required
- Advanced degree in the health sciences (MD, PharmD, PhD)
- Additional master's degree in business or health economics (e.g., MBA, MS)
- Minimum of 5 years post-doctoral relevant scientific work experience in pharmaceutical industry or managed markets
- At least 2 years in a field-based payer/outcomes role
- Demonstrated proficiency managing knowledge across multiple therapeutic areas
- Experience in neurology, hematology, and oncology
- In-depth knowledge of biopharmaceutical industry and US managed markets (Managed Care, Medicare Part B/Part D, Medicaid, VA/DoD, CMS)
- Expertise in health outcomes, health care policy, HTA, and pharmacoeconomic principles (AMCP dossiers, PIE Act, 21st Century Cures Act, ICER, economic models)
- Excellent analytical, written, and verbal communication; experience presenting medical and health economic data to payers and internal stakeholders
- Strong strategic-thinking, networking skills, and ability to create and influence value propositions
- Strong personal integrity, interpersonal skills, teamwork, and customer focus
- Ability to organize, adapt, prioritize, and work effectively in a matrixed, changing healthcare environment
- Ability to travel approximately 50-60% of the time
Jazz Pharmaceuticals, Inc Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Jazz Pharmaceuticals, Inc and has not been reviewed or approved by Jazz Pharmaceuticals, Inc.
-
Fair & Transparent Compensation — Fair & Transparent Compensation: Pay is considered competitive to strong versus biopharma peers, reinforced by market-competitive ranges in public postings. Company materials emphasize a robust total-rewards mix of base, bonus, and equity.
-
Parental & Family Support — Parental & Family Support: Global paid child-bonding leave for all parents and paid caregiver leave are explicitly offered. Additional paid time elements like bereavement and a Global Volunteer Day expand family and life-event support.
-
Wellbeing & Lifestyle Benefits — Wellbeing & Lifestyle Benefits: A market-leading mental-health program provides extensive counseling and coaching access via Lyra. A Wellbeing Reimbursement Account and wellness resources broaden everyday lifestyle support.
Jazz Pharmaceuticals, Inc Insights
What We Do
Jazz Pharmaceuticals plc (Nasdaq: JAZZ), is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with serious diseases—often with limited or no options—so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again. Founded in 2003 and headquartered in Dublin, Ireland, Jazz Pharmaceuticals has a significant corporate presence in Palo Alto, CA, Philadelphia, PA and Oxford, England, with manufacturing facilities in Ireland and Italy. We maintain a highly collaborative culture where employees focus on how they can be successful and accomplish positive results by exemplifying the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. Together, we are more than 3,100 experts, analysts, specialists, advocates, scientists and professionals all with diverse backgrounds and perspectives. Working together, we are proud to support patients, innovate and bring new medicines to market. For more information, please see our website at www.jazzpharma.com and follow us on Twitter at @JazzPharma. For information on fraudulent schemes involving our company name and recruitment, please visit https://bit.ly/2J1EjMA. For guidelines on engaging with Jazz on social media, please visit https://bit.ly/2OaMOuq.








